The -786 T/C polymorphism of NOS3 gene is a susceptibility marker of COPD among Tunisians that correlates with nitric oxide levels and airflow obstruction

•This report investigates the role of -786T/C, G894T and 4B/4A SNPs of NOS3 gene on COPD.•A significant correlation was found between NOS3 G894T and -786T/C variants and COPD risk.•The -786T/C SNP correlates with disease severity and airflow limitation. The goal of this study was to examine the role...

Full description

Saved in:
Bibliographic Details
Published in:Cytokine (Philadelphia, Pa.) Pa.), 2017-05, Vol.93, p.66-73
Main Authors: Ben Nasr, Hela, Bchir, Sarra, ben Anes, Amel, Amri, Asma, Sakhana, Yosra, Benzarti, Mohamed, Garrouch, Abdelhamid, Tabka, Zouhair, Chahed, Karim
Format: Article
Language:English
Subjects:
Aged
Chronic obstructive pulmonary disease
Female
Genetic Markers
Genetic Predisposition to Disease
Humans
Male
Malondialdehyde
Middle Aged
Nitric oxide
Nitric Oxide - blood
Nitric Oxide - genetics
Nitric Oxide Synthase Type III - genetics
Nitric Oxide Synthase Type III - metabolism
NOS3
Polymorphism, Single Nucleotide
Polymorphisms
Pulmonary Disease, Chronic Obstructive - blood
Pulmonary Disease, Chronic Obstructive - genetics
Pulmonary Disease, Chronic Obstructive - physiopathology
Tunisia
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:•This report investigates the role of -786T/C, G894T and 4B/4A SNPs of NOS3 gene on COPD.•A significant correlation was found between NOS3 G894T and -786T/C variants and COPD risk.•The -786T/C SNP correlates with disease severity and airflow limitation. The goal of this study was to examine the role of G894T (rs1799983), -786T/C (rs3918161) and a 27 bp variable number of tandem repeats (VNTR) 4B/4A of NOS3 gene on the risk and severity of COPD. The study included 194 controls and 138 COPD patients. NOS3 G894T, -786T/C and 4B/4A variants were determined by PCR analysis based on the banding pattern on gel electrophoresis. Pulmonary function was evaluated using body plethysmography. The levels of nitric oxide, peroxynitrite and lipid peroxides (T-BARS) were determined using spectrophotometric methods. Levels of serum IL-6, TNF-α and TGFβ were determined by ELISA. In case-control studies, both G894T and -786T/C variants were associated with COPD risk. A significantly increased risk of COPD was found with the NOS3894T and -786C alleles (OR:1.93, P=0.001; OR:2.05, P=0.001, respectively). No significant impact of the G894T and 4B/4A SNPs was found on COPD severity, while a significant correlation was retrieved between the NOS3 -786T/C variation and advanced stages (OR: 1.89, P=0.009). In addition, COPD patients with the -786CC genotype exhibited lower FEV1% values in comparison to -786TT carriers (48±3.28 vs. 58.06±2.3, P=0.01, respectively). Patients having the -786CC genotype presented lower plasma levels of nitric oxide and higher T-BARS in comparison to -786TT individuals (173.22±13.4 vs. 228.93±16.8, P=0.01; 1.8±0.15 vs. 1.22±0.15, P=0.01, respectively). This study provides the first evidence for the association of G894T, -786T/C variants with COPD risk among Tunisians. The -786T/C variation correlates with enhanced airflow limitation. This finding could be related to altered levels of nitric oxide and enhanced lipid peroxides among patients carrying the -786CC genotype.
ISSN:1043-4666
1096-0023
DOI:10.1016/j.cyto.2017.05.010